Review highlights pharmacological uses of toxins in cancer therapy and dental anesthesia, suggesting new treatment avenues.
Advances in microbiology and pharmacology have heralded a new age for toxins. Plant and animal toxins, once hailed as too poisonous for human utilization, are now viewed as the wave of the future. Different permuted forms of toxins are in market circulation, and more so are being developed and approved. Its current and potential uses vary from cancer therapy to treating inflammation and pain. The review intends to provide an integrated overview of the pharmacological aspects of toxins, their mechanisms of action, medical and dental use, recent advances, and their therapeutic approaches. It also addresses the challenges, gaps in research, and future directions in toxin research, emphasizing their interaction with hyaluronic acid. Engineered toxins could revolutionize dental anesthesia, provide effective alternatives to opioids and local anaesthetics, and reduce the risk of tolerance, addiction, or systemic side effects. Hence, toxins open up a new area of dental pharmacotherapy that could improve clinical results and patient comfort.
No takes yet. Share an insight, caveat, or question.
Arora et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: